Clinical study of evaluation of F-MISO PET in patients with oral cancer.

Clinical study of evaluation of F-MISO PET in patients with oral cancer. - Evaluation of oral cancer and F-MISO PET

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017315

Enrollment

Registered

2015-04-28

Start date

2012-05-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Inpatients with oral cancer who will receive surgery in Hokkaido University Hospital. 2) 20 years old or older. 3) Document agreement by the free will of the person

Exclusion criteria

Exclusion criteria: 1) Inadequacy and judgment

Design outcomes

Primary

Measure	Time frame
HIF-1 alfa expression and SUV max or tumor-muscle ratio (TMR) of FMISOPET	—

Secondary

Measure	Time frame
Histological response of radiation or chemotherapy and FMISO PET uptake.	—

Countries

Japan

Contacts

Public ContactYoshimasa Kitagawa

Graduate School of Dental Medicine, Hokkaido University Oral Diagnosis and Medicine, Department of Oral Pathobiological Science

ykitagaw@den.hokudai.ac.jp(011)7064280

Outcome results